MedPath

MAR-PRAVASTATIN

MAR-PRAVASTATIN

Approved
DIN Number

02432064

Drug Class

Human

Market Date

Apr 5, 2018

Company
HC

marcan pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02432064
AIG Number0122563003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AA03 PRAVASTATIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PRAVASTATIN SODIUMActive
Strength: 40 MG
Monograph: PRAVASTATIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.